Skip to main content
. 2024 Oct 1;15:1418870. doi: 10.3389/fphar.2024.1418870

FIGURE 5.

FIGURE 5

Free efalizumab concentrations over time in human following intravenous administration of (A) 0.1 mg/kg, (B) 0.3 mg/kg, (C) 1.0 mg/kg, (D) 3.0 mg/kg, (E) 10 mg/kg. Lines: Simulations, points: observed data (Bauer et al., 1999).